SELLAS Life Sciences Group, Inc. (SLS)
2.08
+0.07
(+3.48%)
USD |
NASDAQ |
Dec 12, 10:45
SELLAS Life Sciences Group Research and Development Expense (TTM): 15.73M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Geron Corp. | 81.32M |
| GT Biopharma, Inc. | 4.026M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |